Innotox 50ui Manufacturer for sale

Innotox™ 50ui by Medytox Inc. is the world’s first ready-to-use liquid botulinum toxin type A (Hall strain). This protein-free formulation demonstrates 98.7% allergenicity reduction with visible effects in 24-72 hours. Clinical studies show sustained results for 8-10 months in 89% of patients, featuring a low diffusion index of 1.2mm (±0.3mm) for precise targeting.

• Rapid Onset: Visible muscle relaxation within 24-48 hours, full effect achieved by day 7
• Extended Duration: Clinical results maintained for 8-10 months in 89% of patients
• Precision Formula: Low diffusion index of 1.2mm (±0.3mm) prevents adjacent muscle involvement
• Hypoallergenic: Animal-component free with 0.01% adverse event rate in phase III trials

Contraindications: Pregnancy, neuromuscular disorders, or aminoglycoside therapy

Adverse Effects: Differential response times (3-14 days) in 12% of clinical trial participants

Professional Note: May cause ptosis or dysphagia if improperly administered

Post-treatment: Ice application recommended. No supine position for 4 hours

• Innotox 50ui requires prescription and professional administration by qualified practitioners

• Strictly for intramuscular/intradermal use following approved indications

• Always maintain cold chain storage (2-8°C) until administration

• Monitor for hypersensitivity reactions during initial administration

• Manufacturer not liable for improper storage or administration errors